Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis
- PMID: 32440977
- DOI: 10.1007/s12325-020-01383-1
Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis
Abstract
Purpose: To evaluate, by laser photometry, the persistency of anterior chamber flare after uneventful phacoemulsification in asymptomatic patients with no signs of inflammation on slit lamp examination.
Method: Seventy-five patients previously enrolled in a randomized clinical trial that evaluated inflammation after uneventful phacoemulsification in eyes treated with dexamethasone 0.1% ophthalmic suspension (group 1) or bromfenac 0.09% ophthalmic solution (group 2) for 2 weeks. Anterior chamber inflammation was investigated by laser flare photometry. At 30 days after surgery, laser flare showed persistently elevated values. For this reason, patients were further analyzed at 3 and 6 months. Additionally, optical coherence tomography was used to measure the central macular thickness (CMT) and to assess for postoperative pseudophakic macular edema.
Results: When compared to preoperative values, laser flare photometry demonstrated persistent ocular inflammation at postoperative days 90 and 180 in group 1, but not in group 2. Laser flare values showed a significant reduction in group 2 compared to group 1 throughout all the follow-up (p < 0.001). The increase in mean CMT at days 90 and 180 with respect to baseline was statistically significant in group 1 but not in group 2, in which it decreased to levels similar to preoperative value. Group 1 showed a higher increase in mean CMT compared to group 2 throughout all the follow-up (p < 0.001). The proportion of patients that developed pseudophakic cystoid macular edema (CME) was 14% (n = 5) and 0% (n = 0) in group 1 and group 2, respectively (p = 0.02). The bivariate analysis demonstrated a positive correlation between laser flare and CMT values in group 1 but not in group 2.
Conclusion: Anterior chamber inflammation persists for more than 30 days in a significant proportion of patients after uncomplicated cataract surgery and may be responsible for late onset of cystoid macular edema cases.
Trial registration: ClinicalTrials.gov identifier, NCT03317847.
Keywords: Cataract surgery; Laser flare photometry; Non-steroidal anti-inflammatory drugs.
Similar articles
-
Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1.Adv Ther. 2019 Oct;36(10):2712-2722. doi: 10.1007/s12325-019-01076-4. Epub 2019 Sep 3. Adv Ther. 2019. PMID: 31482510 Clinical Trial.
-
Laser flare and cell photometry to measure inflammation after cataract surgery: a tool to predict the risk of cystoid macular edema.Int Ophthalmol. 2021 Jun;41(6):2293-2300. doi: 10.1007/s10792-021-01779-0. Epub 2021 Mar 21. Int Ophthalmol. 2021. PMID: 33745035 Review.
-
Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.J Cataract Refract Surg. 2015 Oct;41(10):2043-8. doi: 10.1016/j.jcrs.2015.10.061. J Cataract Refract Surg. 2015. PMID: 26703278 Clinical Trial.
-
The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery.Curr Eye Res. 2018 Dec;43(12):1445-1453. doi: 10.1080/02713683.2018.1501489. Epub 2018 Jul 27. Curr Eye Res. 2018. PMID: 30009640 Clinical Trial.
-
Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery.Expert Opin Pharmacother. 2019 Oct;20(14):1703-1709. doi: 10.1080/14656566.2019.1645834. Epub 2019 Jul 25. Expert Opin Pharmacother. 2019. PMID: 31343372 Review.
Cited by
-
Laser flare photometry in uveitis.Saudi J Ophthalmol. 2022 Dec 27;36(4):337-343. doi: 10.4103/sjopt.sjopt_119_22. eCollection 2022 Oct-Dec. Saudi J Ophthalmol. 2022. PMID: 36618569 Free PMC article.
-
Anterior chamber flare and choroidal vascular index as inflammatory markers after uncomplicated phacoemulsification surgery.Int Ophthalmol. 2024 Feb 8;44(1):35. doi: 10.1007/s10792-024-02959-4. Int Ophthalmol. 2024. PMID: 38332452
-
Changes in Macular Thickness after Cataract Surgery in Patients with Open Angle Glaucoma.Diagnostics (Basel). 2023 Jan 9;13(2):244. doi: 10.3390/diagnostics13020244. Diagnostics (Basel). 2023. PMID: 36673054 Free PMC article.
-
Laser Flare Photometry to Monitor Childhood Chronic Uveitis: A Preliminary Report of a Monocentric Italian Experience.Diagnostics (Basel). 2023 Oct 11;13(20):3179. doi: 10.3390/diagnostics13203179. Diagnostics (Basel). 2023. PMID: 37892000 Free PMC article.
-
Epidemiology of uveitis after tuberculosis in Taiwan - A nationwide population-based cohort study.Taiwan J Ophthalmol. 2024 Jul 22;15(2):252-258. doi: 10.4103/tjo.TJO-D-24-00012. eCollection 2025 Apr-Jun. Taiwan J Ophthalmol. 2024. PMID: 40584193 Free PMC article.
References
-
- World Health Organization. Global initiative for the elimination of avoidable blindness: action plan 2006–2011. 2007. https://doi.org/10.1017/CBO9781107415324.004 .
-
- Kim SJ, Schoenberger SD, Thorne JE, et al. Topical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of Ophthalmology. Ophthalmology. 2015. https://doi.org/10.1016/j.ophtha.2015.05.014 . - DOI - PubMed - PMC
-
- McCafferty S, Harris A, Kew C, et al. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo. BMC Ophthalmol. 2017. https://doi.org/10.1186/s12886-017-0405-7 . - DOI - PubMed - PMC
-
- Hoffman RS, Braga-Mele R, Donaldson K, et al. Cataract surgery and nonsteroidal antiinflammatory drugs. J Cataract Refract Surg. 2016. https://doi.org/10.1016/j.jcrs.2016.06.006 . - DOI - PubMed - PMC
-
- Wielders LHP, Schouten JSAG, Winkens B, et al. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1. J Cataract Refract Surg. 2018;44(4):429–39. https://doi.org/10.1016/j.jcrs.2018.01.029 . - DOI - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical